Skip to content

The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)

The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07002294
Acronym
SPARC
Enrollment
1618
Registered
2025-06-03
Start date
2026-05-11
Completion date
2032-01-01
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest (CA), Heart Arrest, Heart Arrest, Out-Of-Hospital

Keywords

cardiac arrest

Brief summary

This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether transferring participants to a hospital with a specialized cardiac arrest service improves recovery of function after 90 days. Participants will receive all usual medical care, but some participants will be offered transfer to a regional cardiac arrest center and others will be offered care at the closest appropriate hospital. Investigators will interview participants after 90 days to assess their recovery.

Detailed description

Cardiac arrest is a sudden stopping of the heart, which can sometimes be reversed by rapid cardiopulmonary resuscitation (CPR) and emergency medical care. Each year, over 150,000 Americans are admitted to the hospital after receiving CPR. However, many of these patients die in the hospital. There is wide variation in patient outcomes between hospitals. A key knowledge gap about systems of care is whether specific hospital or subsequent interventions or processes of care are associated with better patient outcomes. Specifically, it is unknown if patient outcomes are improved by specialized centers or by improved implementation of recommended interventions at all hospitals. Observational data in our region and internationally suggest that out-of-hospital cardiac arrest outcomes are better when patients who survive CPR are hospitalized in specialty care or high-volume centers. It is unclear from these studies what are the minimal capabilities that distinguish specialty care from usual care and which aspects of specialty care are influencing outcomes. This trial will take advantage of a regional system of care that includes 18 hospitals in southwestern Pennsylvania that treat over 1,000 patients resuscitated from out-of-hospital cardiac arrest annually. This region includes one high-volume specialty center with specific attention to recommended interventions for this patient population, as well as several secondary and tertiary care facilities with variable resources and approaches to patient care. This randomized trial will compare outcomes for patients assigned to care at the specialty center versus other centers and will leverage the heterogeneity of treatment between centers to understand the influence of specific treatments.

Interventions

OTHERTransfer to specialty care

Interfacility transport and treatment at the specialty care hospital

OTHERUsual care

Hospitalization and treatment at the closest appropriate facility

Sponsors

University of Pittsburgh
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Out-of-hospital cardiac arrest * Resuscitated from cardiac arrest with palpable pulse in the emergency department * Treated at one of participating hospital emergency departments * Age ≥18 years

Exclusion criteria

* Known prior advanced directives or decision to limit critical care * Known pre-arrest dependent functional status (e.g., living in a skilled nursing facility, hospice or bedbound) * Arrest in the emergency department \>4 hours after arrival * Traumatic etiology of arrest * Known to have opted-out from the SPARC trial

Design outcomes

Primary

MeasureTime frameDescription
Modified Rankin Scale90 Days post arrestThe Modified Rankin Scale (mRS) is a measure of functional recovery, measured 90 days after cardiac arrest. A Modified Rankin Score (mRS) of 0 corresponds to full functional recovery and a Modified Rankin Score (mRS) of 6 corresponds to death, with progressively worse functional outcomes at higher scores. Intermediate values reflect progressive functional dependence, with higher scores reflecting greater dependence on others.

Secondary

MeasureTime frame
Survival to ICU Admission24 hours post arrest
72 hour survival72 hours post arrest
mRS at hospital dischargeUp to 6 months post arrest

Countries

United States

Contacts

CONTACTSara DiFiore-Sprouse
difioresm@upmc.edu4128642284
PRINCIPAL_INVESTIGATORJonathan Elmer, MD, MS

University of Pittsburgh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026